Proove Bioscience
- Thread starter Anonymous
- Start date
-
- Tags
- None
in my opinion I see a pattern of dysfunctional behavior across the whole tribe. Possible gene mutations that have infected all generations..
Is there a test for that?
Is there a test for that?
When I first began working for Proove I was all in. I was excited to be a part of something that was really making a difference in patients lives. I was an advocate for Proove and supported, no matter what. What a joke this company turned out to be. Brian Meshkin- karma will come around and with all that you have done to so many people, I am certain will have something truly special for you. I can only hope that we all get to see it happen. We all know it's just a matter of time before the company closes. Word has it, that you are trying to stretch it to the end of the year. I honestly don't know how you can look at yourself in the mirror each day. You have ruined lives. Employees didn't accept job offers and expect not to be paid for the work they did for you. You owe wages to employees that depended on their paycheck as a means of survival. Sales representatives weren't paid owed commissions for selling your product s. And despite your legal contracts and agreements with physicians you have not paid physicians for their research time since last August.
According to this board, it's likely that you read the posts here, or at least your loyal followers do. So how about you man up and admit you screwed up and that you yourself are a fraud. Shame on you Brian Meshkin- some CEO you are. How's your ratings now? No one cares about the Proove Facebook Posts, Twitter and Instagram any longer. You have now lost credibility with your employees, along with former sales reps and the physicians current and past that you scammed. Pay your furloughed employees the wages they are owed. Settle your debts with sales representatives and physicians. Start liquidating assets and make good with these people that at one time believed in Proove.
According to this board, it's likely that you read the posts here, or at least your loyal followers do. So how about you man up and admit you screwed up and that you yourself are a fraud. Shame on you Brian Meshkin- some CEO you are. How's your ratings now? No one cares about the Proove Facebook Posts, Twitter and Instagram any longer. You have now lost credibility with your employees, along with former sales reps and the physicians current and past that you scammed. Pay your furloughed employees the wages they are owed. Settle your debts with sales representatives and physicians. Start liquidating assets and make good with these people that at one time believed in Proove.
I was a PER. I worked in a small Family practice in VA. About 4-5 months in tinny employment I started getting a funny feeling about the patients I was swabbing. Because my practice was so small I was getting repeat patients, thus, my enrollments went down. I emailed my supervisor and asked if I was supposed to be swabbing patients who didn't have a diagnoses of anything related to pain. Her response, was to swan every single patient whose insurance qualified, no matter what the diagnoses is. Bottom line, I was swabbing patients who were coming to see the doctor for something as simple as a cold, or pink eye. It did NOT feel right at all. Then, on May 4th, my doc pulled me in to his office and told me that he has not been paid a single penny since he started with Proove in October. He is actually the one who advised me to leave the company. I got 2-3 phone calls from PATIENTS who had received multiple bills in the mail. I asked them if they were certain it was a bill and not the EOB, to which they all responded yes. Proove was sending them bills one patient received the a bill 4 times. EOBs are only sent once...
So, how are those super stellar TSSs that Proove wasted, err, spent all that money on doing? The training, the travel (especially for the tryst between KP and JP) all for two people to interview and hire salespeople when neither of them know the first thing about sales?
What a freaking joke. Brian, not saying that Rhonda didn't need to go, but KP was definitely not the person for the job. That was the beginning of Proove's downfall.
What a freaking joke. Brian, not saying that Rhonda didn't need to go, but KP was definitely not the person for the job. That was the beginning of Proove's downfall.
Just pay your employees you ***** WEASEL!!!!! Use your pocket full of Benjamins!!!! A lot of employees have kids and family to feed YOU worthless piece of GARBAGE.
We are all ANXIOUSLY waiting to hear the findings from the FBI. People are ready to leak it out any breaking story from you and all the world will see your name in the paper. Proove Biosciences is not out of the woods.
Brian Meshkin "successful entrepreneur"
Entrepreneur my @$$!!!!
you are trash Meshkin. You make me sick.
You are going to jail for Insurance fraud Meshkin. You will be behind bars and you will Repay the insurances millions of dollars. Your mistakes cost so much harm to everyone in the company including myself. Social media is getting ready to rumble
We are all ANXIOUSLY waiting to hear the findings from the FBI. People are ready to leak it out any breaking story from you and all the world will see your name in the paper. Proove Biosciences is not out of the woods.
Brian Meshkin "successful entrepreneur"
Entrepreneur my @$$!!!!
you are trash Meshkin. You make me sick.
You are going to jail for Insurance fraud Meshkin. You will be behind bars and you will Repay the insurances millions of dollars. Your mistakes cost so much harm to everyone in the company including myself. Social media is getting ready to rumble
Whoever is not being paid call the department of labor! They work miracles
Are you saying you got paid with the help of the deparment of labor?
Interesting:
Proove Biosciences Linked to Fraud Investigation
July 14, 2017
By Pat Anson, Editor
A controversial genetic testing company in southern California has been linked to a nationwide crackdown on healthcare fraud that resulted in criminal charges being filed against hundreds of doctors, nurses and medical professionals.
Among the defendants are three individuals affiliated with Physicians Primary Care of Jeffersonville, Indiana, who are accused of unlawfully dispensing oxycodone, hydrocodone and other opioid medications to patients without a legitimate medical need.
The charges also allege that Jeffrey Campbell, MD, and nurse practitioners Mark Dyer and Dawn Antle "caused Proove Bioscience, Inc., a genetic lab company, to falsely and fraudulently bill various health care programs for genetic tests administered to Physicians Primary Care patients that were not medically necessary and never interpreted."
Proove Biosciences is not formally charged in the grand jury indictment, which was unsealed yesterday in the U.S. District Court of Kentucky in Louisville. A request to the company for comment was not returned.
As PNN has reported, Proove’s headquarters in Irvine, California was raided by FBI agents last month, along with doctors affiliated with Proove in California, Florida and Kentucky. At the time, the FBI would only say the raids were part of a healthcare fraud investigation.
STAT News reported in February that the FBI and the Inspector General for the Department of Health and Human Services (HHS) were investigating possible criminal activity at Proove. Former and current employees interviewed by the FBI said agents were focused on illegal kickbacks to doctors who encouraged patients to take Proove’s DNA tests. Physicians reportedly could make $144,000 a year in kickbacks that were called “research fees.”
"Proove has been subject to a handful of inaccurate stories,” Proove said in a statement last month. “We can no longer ignore these false stories based on unreliable sources, and filled with erroneous accusations... spread by a few disgruntled former employees and consultants.”
In all, 412 defendants have been charged nationwide in what the Justice Department calls its “largest ever health care fraud enforcement action.” Most of the charges, according to prosecutors, involve the illegal distribution of painkillers and $1.3 billion in various billing schemes that targeted Medicare, Medicaid and TRICARE, a health insurance program for veterans and their families.
Attorney General Jeff Sessions said nearly 300 health care providers were being suspended or banned from participating in federal health programs.
“Too many trusted medical professionals like doctors, nurses, and pharmacists have chosen to violate their oaths and put greed ahead of their patients,” said Sessions. “Amazingly, some have made their practices into multi-million dollar criminal enterprises. They seem oblivious to the disastrous consequences of their greed. Their actions not only enrich themselves often at the expense of taxpayers but also feed addictions and cause addictions to start.”
Proove’s ‘Peer Reviewed’ Studies
Proove Biosciences promotes itself as a “leader in personalized pain medicine” and claims its genetic tests have been proven effective in clinical studies at identifying medications that can best treat pain and other health conditions. Critics say most Proove studies are not peer-reviewed and one genetic expert told STAT News the studies were “hogwash.”
Last month Proove claimed in a press release that 91% of patients in a peer-reviewed study reported pain relief after treatment changes prompted by its genetic tests. The press release said the study -- conducted by Katrina Lewis, MD,a member of Proove's medical advisory board who works at Benefis Pain Management Center in Great Falls, Montana – was “accepted for publication by the Journal of Addiction Research & Therapy.”
Not only has the study still not been published, but the journal’s publisher has been accused by the Federal Trade Commission (FTC) of deceiving researchers and readers about the true nature of its publications and peer review process.
According to the FTC complaint filed last August,OMICS International has created hundreds of "open access" online medical journals that publish articles with little or no peer review.
Researchers are also charged significant fees to get their articles published by OMICS, a "pay to play" policy that some consider unethical because it diminishes the quality of academic journals and the peer review process.
According to its website, OMICS publishes a dizzying array of over 700 online medical and scientific journals, ranging from the Journal of Hepatitis to the Journal of Yoga and Physical Therapy, "the official journal of Yoga Federation of Russia and the Hong Kong Yoga Association."
“In reality, many of Defendants’ online publications do not adopt the rigorous peer review practices that are standard in the scholarly journal publishing industry,” the FTC complaint says. “In numerous instances, individuals who have agreed to serve as peer reviewers for Defendants either never receive any manuscripts to review or discover that, when they access the online manuscript review system to review their assigned articles, the articles have already been approved for publication. In addition, in numerous instances, consumers receive no edits or, at most, only stylistic edits before Defendants publish the work.”
In March, OMICS published in the Journal of Addiction Research & Therapy a study by Proove which found that one of the company’s genetic tests could identify patients at high-risk of developing opioid use disorder. Proove said in a news release the study had been peer reviewed.
In April, a second Proove study was published in Pharmacogenomics and Personalized Medicine, an online journal published by Dove Medical Press, another so-called predatory publisher that charges high fees to researchers to get their studies into medical journals.
"This is the first of many peer-reviewed publications over the next several months demonstrating the validity of Proove Opioid Risk (test), building on the existing published evidence," Dr. Svetlana Kantorovich, Proove's Research and Development director said in a news release.
Proove Biosciences Linked to Fraud Investigation
July 14, 2017
By Pat Anson, Editor
A controversial genetic testing company in southern California has been linked to a nationwide crackdown on healthcare fraud that resulted in criminal charges being filed against hundreds of doctors, nurses and medical professionals.
Among the defendants are three individuals affiliated with Physicians Primary Care of Jeffersonville, Indiana, who are accused of unlawfully dispensing oxycodone, hydrocodone and other opioid medications to patients without a legitimate medical need.
The charges also allege that Jeffrey Campbell, MD, and nurse practitioners Mark Dyer and Dawn Antle "caused Proove Bioscience, Inc., a genetic lab company, to falsely and fraudulently bill various health care programs for genetic tests administered to Physicians Primary Care patients that were not medically necessary and never interpreted."
Proove Biosciences is not formally charged in the grand jury indictment, which was unsealed yesterday in the U.S. District Court of Kentucky in Louisville. A request to the company for comment was not returned.
As PNN has reported, Proove’s headquarters in Irvine, California was raided by FBI agents last month, along with doctors affiliated with Proove in California, Florida and Kentucky. At the time, the FBI would only say the raids were part of a healthcare fraud investigation.
STAT News reported in February that the FBI and the Inspector General for the Department of Health and Human Services (HHS) were investigating possible criminal activity at Proove. Former and current employees interviewed by the FBI said agents were focused on illegal kickbacks to doctors who encouraged patients to take Proove’s DNA tests. Physicians reportedly could make $144,000 a year in kickbacks that were called “research fees.”
"Proove has been subject to a handful of inaccurate stories,” Proove said in a statement last month. “We can no longer ignore these false stories based on unreliable sources, and filled with erroneous accusations... spread by a few disgruntled former employees and consultants.”
In all, 412 defendants have been charged nationwide in what the Justice Department calls its “largest ever health care fraud enforcement action.” Most of the charges, according to prosecutors, involve the illegal distribution of painkillers and $1.3 billion in various billing schemes that targeted Medicare, Medicaid and TRICARE, a health insurance program for veterans and their families.
Attorney General Jeff Sessions said nearly 300 health care providers were being suspended or banned from participating in federal health programs.
“Too many trusted medical professionals like doctors, nurses, and pharmacists have chosen to violate their oaths and put greed ahead of their patients,” said Sessions. “Amazingly, some have made their practices into multi-million dollar criminal enterprises. They seem oblivious to the disastrous consequences of their greed. Their actions not only enrich themselves often at the expense of taxpayers but also feed addictions and cause addictions to start.”
Proove’s ‘Peer Reviewed’ Studies
Proove Biosciences promotes itself as a “leader in personalized pain medicine” and claims its genetic tests have been proven effective in clinical studies at identifying medications that can best treat pain and other health conditions. Critics say most Proove studies are not peer-reviewed and one genetic expert told STAT News the studies were “hogwash.”
Last month Proove claimed in a press release that 91% of patients in a peer-reviewed study reported pain relief after treatment changes prompted by its genetic tests. The press release said the study -- conducted by Katrina Lewis, MD,a member of Proove's medical advisory board who works at Benefis Pain Management Center in Great Falls, Montana – was “accepted for publication by the Journal of Addiction Research & Therapy.”
Not only has the study still not been published, but the journal’s publisher has been accused by the Federal Trade Commission (FTC) of deceiving researchers and readers about the true nature of its publications and peer review process.
According to the FTC complaint filed last August,OMICS International has created hundreds of "open access" online medical journals that publish articles with little or no peer review.
Researchers are also charged significant fees to get their articles published by OMICS, a "pay to play" policy that some consider unethical because it diminishes the quality of academic journals and the peer review process.
According to its website, OMICS publishes a dizzying array of over 700 online medical and scientific journals, ranging from the Journal of Hepatitis to the Journal of Yoga and Physical Therapy, "the official journal of Yoga Federation of Russia and the Hong Kong Yoga Association."
“In reality, many of Defendants’ online publications do not adopt the rigorous peer review practices that are standard in the scholarly journal publishing industry,” the FTC complaint says. “In numerous instances, individuals who have agreed to serve as peer reviewers for Defendants either never receive any manuscripts to review or discover that, when they access the online manuscript review system to review their assigned articles, the articles have already been approved for publication. In addition, in numerous instances, consumers receive no edits or, at most, only stylistic edits before Defendants publish the work.”
In March, OMICS published in the Journal of Addiction Research & Therapy a study by Proove which found that one of the company’s genetic tests could identify patients at high-risk of developing opioid use disorder. Proove said in a news release the study had been peer reviewed.
In April, a second Proove study was published in Pharmacogenomics and Personalized Medicine, an online journal published by Dove Medical Press, another so-called predatory publisher that charges high fees to researchers to get their studies into medical journals.
"This is the first of many peer-reviewed publications over the next several months demonstrating the validity of Proove Opioid Risk (test), building on the existing published evidence," Dr. Svetlana Kantorovich, Proove's Research and Development director said in a news release.
This is a separate investigation. It is pretty clear now that Proove will be indicted for illegal kickbacks and pushing unnecessary and unproven medical tests. Heavy fines and criminal charges are on the way. I fear for the R&D team from that PNN article.
Brian keeps boasting of the validity of its fake tests but the journals he has submitting to are questionable and under investigation. What a guy!
Brian keeps boasting of the validity of its fake tests but the journals he has submitting to are questionable and under investigation. What a guy!
You are so screwed Brian. You have no way out you piece of trash.
It is very clear. That is it Meshkin. There is no light at the end of the tunnel for Proove and for you. JUST GIVE IT UP!!!
It is very clear. That is it Meshkin. There is no light at the end of the tunnel for Proove and for you. JUST GIVE IT UP!!!
Brian has the world by the balls.Just lawyer up with the best defense money can buy and he won't do one day of time. You dumb snowflakes don't know jackshit about the law. Acclarent Pat Fabian and Bill Facteau elite legal team beat a felony and now are appealing misdemeanor charges. You coward dweebs are pathetic !
Svetlana who heads up all the tests, publications should consider getting an attorney in my opinion.
Interesting:
Proove Biosciences Linked to Fraud Investigation
July 14, 2017
By Pat Anson, Editor
A controversial genetic testing company in southern California has been linked to a nationwide crackdown on healthcare fraud that resulted in criminal charges being filed against hundreds of doctors, nurses and medical professionals.
Among the defendants are three individuals affiliated with Physicians Primary Care of Jeffersonville, Indiana, who are accused of unlawfully dispensing oxycodone, hydrocodone and other opioid medications to patients without a legitimate medical need.
The charges also allege that Jeffrey Campbell, MD, and nurse practitioners Mark Dyer and Dawn Antle "caused Proove Bioscience, Inc., a genetic lab company, to falsely and fraudulently bill various health care programs for genetic tests administered to Physicians Primary Care patients that were not medically necessary and never interpreted."
Proove Biosciences is not formally charged in the grand jury indictment, which was unsealed yesterday in the U.S. District Court of Kentucky in Louisville. A request to the company for comment was not returned.
As PNN has reported, Proove’s headquarters in Irvine, California was raided by FBI agents last month, along with doctors affiliated with Proove in California, Florida and Kentucky. At the time, the FBI would only say the raids were part of a healthcare fraud investigation.
STAT News reported in February that the FBI and the Inspector General for the Department of Health and Human Services (HHS) were investigating possible criminal activity at Proove. Former and current employees interviewed by the FBI said agents were focused on illegal kickbacks to doctors who encouraged patients to take Proove’s DNA tests. Physicians reportedly could make $144,000 a year in kickbacks that were called “research fees.”
"Proove has been subject to a handful of inaccurate stories,” Proove said in a statement last month. “We can no longer ignore these false stories based on unreliable sources, and filled with erroneous accusations... spread by a few disgruntled former employees and consultants.”
In all, 412 defendants have been charged nationwide in what the Justice Department calls its “largest ever health care fraud enforcement action.” Most of the charges, according to prosecutors, involve the illegal distribution of painkillers and $1.3 billion in various billing schemes that targeted Medicare, Medicaid and TRICARE, a health insurance program for veterans and their families.
Attorney General Jeff Sessions said nearly 300 health care providers were being suspended or banned from participating in federal health programs.
“Too many trusted medical professionals like doctors, nurses, and pharmacists have chosen to violate their oaths and put greed ahead of their patients,” said Sessions. “Amazingly, some have made their practices into multi-million dollar criminal enterprises. They seem oblivious to the disastrous consequences of their greed. Their actions not only enrich themselves often at the expense of taxpayers but also feed addictions and cause addictions to start.”
Proove’s ‘Peer Reviewed’ Studies
Proove Biosciences promotes itself as a “leader in personalized pain medicine” and claims its genetic tests have been proven effective in clinical studies at identifying medications that can best treat pain and other health conditions. Critics say most Proove studies are not peer-reviewed and one genetic expert told STAT News the studies were “hogwash.”
Last month Proove claimed in a press release that 91% of patients in a peer-reviewed study reported pain relief after treatment changes prompted by its genetic tests. The press release said the study -- conducted by Katrina Lewis, MD,a member of Proove's medical advisory board who works at Benefis Pain Management Center in Great Falls, Montana – was “accepted for publication by the Journal of Addiction Research & Therapy.”
Not only has the study still not been published, but the journal’s publisher has been accused by the Federal Trade Commission (FTC) of deceiving researchers and readers about the true nature of its publications and peer review process.
According to the FTC complaint filed last August,OMICS International has created hundreds of "open access" online medical journals that publish articles with little or no peer review.
Researchers are also charged significant fees to get their articles published by OMICS, a "pay to play" policy that some consider unethical because it diminishes the quality of academic journals and the peer review process.
According to its website, OMICS publishes a dizzying array of over 700 online medical and scientific journals, ranging from the Journal of Hepatitis to the Journal of Yoga and Physical Therapy, "the official journal of Yoga Federation of Russia and the Hong Kong Yoga Association."
“In reality, many of Defendants’ online publications do not adopt the rigorous peer review practices that are standard in the scholarly journal publishing industry,” the FTC complaint says. “In numerous instances, individuals who have agreed to serve as peer reviewers for Defendants either never receive any manuscripts to review or discover that, when they access the online manuscript review system to review their assigned articles, the articles have already been approved for publication. In addition, in numerous instances, consumers receive no edits or, at most, only stylistic edits before Defendants publish the work.”
In March, OMICS published in the Journal of Addiction Research & Therapy a study by Proove which found that one of the company’s genetic tests could identify patients at high-risk of developing opioid use disorder. Proove said in a news release the study had been peer reviewed.
In April, a second Proove study was published in Pharmacogenomics and Personalized Medicine, an online journal published by Dove Medical Press, another so-called predatory publisher that charges high fees to researchers to get their studies into medical journals.
"This is the first of many peer-reviewed publications over the next several months demonstrating the validity of Proove Opioid Risk (test), building on the existing published evidence," Dr. Svetlana Kantorovich, Proove's Research and Development director said in a news release.
I suppose if your primary goal is to beat the rap and avoid the big house possibly you are right.
If your goal is to have a rep to lay the rest of your career and life on well .. perhaps you should not be so flippant
Current mgt are associated with some very bad history that will last a
Lifetime in my opinion
If your goal is to have a rep to lay the rest of your career and life on well .. perhaps you should not be so flippant
Current mgt are associated with some very bad history that will last a
Lifetime in my opinion
Facteau is now CEO at EarLens. Looks like his career isn't diminished at all.
Every crime is different. You cannot use one situation to judge the outcome of another. Many powerful people go to prison everyday even with thier high power attorneys.
Brian has been involved in blatant fraud and i doubt if he will walk away from this. The level of unethical and lllegal practices at Proove is mind blowing and the FBI, OIG and HHS will definitely go after Brian.
The case against Brian and Proove is a slam dunk in my opinion.
Wake up and smell the roses. $Money$ talks and felons walk It's the nature of the beast.
Deep pockets = misdemeanor = no time served. Sorry to expand your narrow mind.
Deep pockets = misdemeanor = no time served. Sorry to expand your narrow mind.
If those pockets are so deep and Meshkin has all kinds of money, then do tell why he can't seem to pay his employees the wages they have earned? Or commissions owed to sales representatives?
Because shit rolls downhill and unfortunately you are at the bottom. Do you comprehend?
My advice is to quit and find a more stable company. I wish justice would be served and this guy is locked up, but when players are defendants the deck is stacked in thier favor. In the end, Karma will catch up to him and no attorney, money, or crooked judge will be able to stop it.
My advice is to quit and find a more stable company. I wish justice would be served and this guy is locked up, but when players are defendants the deck is stacked in thier favor. In the end, Karma will catch up to him and no attorney, money, or crooked judge will be able to stop it.